Tenax Therapeutics (TENX) Depreciation & Amortization (CF) (2010 - 2023)
Tenax Therapeutics (TENX) posted quarterly Depreciation & Amortization (CF) of $5136.0 for Q4 2023, up 281.86% year-over-year from $1345.0 in Q4 2022, and up 430.03% on a QoQ basis from $969.0 in Q3 2023.
Tenax Therapeutics (TENX) Depreciation & Amortization (CF) (2010 - 2023) Analysis & Trends
Tenax Therapeutics has reported Depreciation & Amortization (CF) for 14 years, with the latest figure at $5136.0 in Q4 2023.
- Depreciation & Amortization (CF) for Q4 2023 came in at $5136.0, up 281.86% year-over-year; the trailing twelve-month figure through Sep 2024 was $5136.0 (up 22.02% YoY), and the FY2023 annual result was $8000.0, up 55.55% from the prior year.
- Depreciation & Amortization (CF) improved to $5136.0 in Q4 2023, from $969.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $5136.0 in Q4 2023 and troughed at $891.0 in Q2 2021.
- A 5-year average of $1317.6 and a median of $1113.5 in 2019 frame the typical range for Depreciation & Amortization (CF).
- The widest annual swing landed in 2019, when Depreciation & Amortization (CF) sank 56.74%; it then soared 281.86% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $1308.0 in 2019, then slipped by 25.15% to $979.0 in 2020, then grew by 10.21% to $1079.0 in 2021, then grew by 24.65% to $1345.0 in 2022, then soared by 281.86% to $5136.0 in 2023.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $5136.0 in Q4 2023, $969.0 in Q3 2023, and $1000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5,136.00 |
| Dec 31, 2023 | 5,136.00 |
| Sep 30, 2023 | 969.00 |
| Sep 30, 2023 | 969.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 895.00 |
| Mar 31, 2023 | 895.00 |
| Dec 31, 2022 | 1,345.00 |
| Dec 31, 2022 | 1,345.00 |
| Sep 30, 2022 | 1,210.00 |
| Sep 30, 2022 | 1,210.00 |
| Jun 30, 2022 | 1,235.00 |
| Jun 30, 2022 | 1,235.00 |
| Mar 31, 2022 | 1,353.00 |
| Mar 31, 2022 | 1,353.00 |
| Dec 31, 2021 | 1,079.00 |
| Dec 31, 2021 | 1,079.00 |
| Sep 30, 2021 | 1,011.00 |
| Sep 30, 2021 | 1,011.00 |